One stock in the biotechnology and drugs complex that's trading within range of a major breakout trade is pSivida (PSDV), which, together with its subsidiaries, develops drug delivery products for treatment of back-of-the-eye diseases that are administered by implantation, injection, or insertion. This stock is off to a monster start in 2012 with shares up over 110%.
If you look at the chart for pSivida, you'll see that this stock dropped pretty hard once it hit its April high of $2.55, since shares then dropped to a low of $1.76 a share in June. During that sharp slide lower, shares of PSDV were making lower highs and lower lows, which is bearish technical price action. That said, during the last month shares of pSivida have formed a double bottom chart pattern at around $1.76 to $1.78 a share. That bottom brought in buyer who have pushed the stock back above both its 50-day and 200-day moving averages. Now shares of pSivida are trading within range of a major breakout trade.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV